Jones, C., Mische, S., Blount, K., & Shannon, B. (2019). 669. Twelve-Month Durability of Microbiota-Based Therapy RBX2660 for Prevention of Recurrent Clostridium difficile Infection. Open Forum Infect Dis.
Chicago Stili AlıntıJones, Courtney, Sarah Mische, Ken Blount, ve Bill Shannon. "669. Twelve-Month Durability of Microbiota-Based Therapy RBX2660 for Prevention of Recurrent Clostridium Difficile Infection." Open Forum Infect Dis 2019.
MLA AlıntıJones, Courtney, Sarah Mische, Ken Blount, ve Bill Shannon. "669. Twelve-Month Durability of Microbiota-Based Therapy RBX2660 for Prevention of Recurrent Clostridium Difficile Infection." Open Forum Infect Dis 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..